Acer Medical Inc.(TW:6857)
NT$89.00-1.00 (-0.56%)
TW:6857
Acer Medical Inc. financials statements
NT$89.00
At close:-1.00 (-0.56%)
Acer Medical Inc. (6857) Ratios
Acer Medical Inc. Ratios
TW:6857's free cash flow for Q2 2026 was NT$-19.37M. For the 2026 fiscal year, TW:6857's free cash flow was decreased by NT$-695.00K and operating cash flow was NT$-18.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.74 | 6.84 | 6.66 | 9.41 | 6.19 |
| Quick Ratio | 4.60 | 6.72 | 6.34 | 9.41 | 6.16 |
| Cash Ratio | 4.16 | 6.28 | 5.87 | 9.21 | 2.26 |
| Solvency Ratio | -0.67 | -0.81 | -0.98 | -1.80 | -0.93 |
| Operating Cash Flow Ratio | -0.58 | -0.64 | -1.42 | -1.52 | -0.86 |
| Short-Term Operating Cash Flow Coverage | -9.55 | -243.52 | -13282.50 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 158.11M | NT$ 188.59M | NT$ 212.37M | NT$ 252.64M | NT$ 114.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.17 | 1.17 | 1.12 | 1.19 |
| Debt Service Coverage Ratio | -12.15 | -340.75 | -9963.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -2518.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.17 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 5.51 | 7.00 | 5.52 | 5.07 | 2.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.94% | 63.15% | 46.94% | 46.98% | 66.85% |
| EBIT Margin | -54.51% | -60.20% | -149.96% | -422.49% | -212.38% |
| EBITDA Margin | -52.45% | -57.75% | -145.19% | -417.32% | -211.59% |
| Operating Profit Margin | -54.51% | -60.20% | -149.96% | -422.49% | -212.38% |
| Pretax Profit Margin | -49.43% | -54.56% | -139.10% | -418.88% | -212.38% |
| Net Profit Margin | -49.43% | -54.56% | -139.10% | -418.88% | -212.38% |
| Continuous Operations Profit Margin | -49.43% | -54.56% | -139.10% | -418.88% | -212.38% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 90.69% | 90.62% | 92.76% | 99.15% | 100.00% |
| Return on Assets (ROA) | -14.33% | -12.06% | -14.72% | -18.85% | -14.95% |
| Return on Equity (ROE) | -18.00% | -14.06% | -17.20% | -21.03% | -17.81% |
| Return on Capital Employed (ROCE) | -19.85% | -15.52% | -18.55% | -21.21% | -17.81% |
| Return on Invested Capital (ROIC) | -19.54% | -15.51% | -18.55% | -21.21% | -17.81% |
| Return on Tangible Assets | -14.55% | -12.27% | -14.98% | -19.14% | -14.99% |
| Earnings Yield | -1.97% | -1.27% | -1.34% | -6.07% | -2.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.05 | 4.45 | 1.79 | 2.86 | 2.07 |
| Payables Turnover | 9.84 | 11.24 | 1.73 | 8.05 | 3.99 |
| Inventory Turnover | 3.98 | 4.97 | 1.20 | 53.26 | 4.19 |
| Fixed Asset Turnover | 31.20 | 27.56 | 11.48 | 4.18 | 21.68 |
| Asset Turnover | 0.29 | 0.22 | 0.11 | 0.05 | 0.07 |
| Working Capital Turnover Ratio | 0.35 | 0.25 | 0.12 | 0.07 | 0.13 |
| Cash Conversion Cycle | 126.83 | 123.04 | 296.48 | 88.99 | 172.07 |
| Days of Sales Outstanding | 72.32 | 82.06 | 203.35 | 127.47 | 176.41 |
| Days of Inventory Outstanding | 91.61 | 73.45 | 304.02 | 6.85 | 87.05 |
| Days of Payables Outstanding | 37.10 | 32.48 | 210.90 | 45.34 | 91.39 |
| Operating Cycle | 163.93 | 155.52 | 507.38 | 134.32 | 263.46 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.62 | -1.36 | -3.49 | -3.71 | -2.43 |
| Free Cash Flow Per Share | -1.69 | -1.36 | -3.54 | -4.31 | -2.54 |
| Dividend Paid and CapEx Coverage Ratio | -22.84 | 0.00 | -69.72 | -6.18 | -21.75 |
| Capital Expenditure Coverage Ratio | -22.84 | 0.00 | -69.72 | -6.18 | -21.75 |
| Operating Cash Flow Coverage Ratio | -9.55 | -243.52 | -13282.50 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.41 | -0.41 | -1.94 | -3.50 | -1.95 |
| Free Cash Flow Yield | -1.71% | -0.96% | -1.89% | -5.90% | -2.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -50.77 | -78.89 | -74.50 | -16.48 | -45.41 |
| Price-to-Sales (P/S) Ratio | 25.10 | 43.11 | 103.73 | 68.95 | 96.54 |
| Price-to-Book (P/B) Ratio | 9.14 | 11.11 | 12.83 | 3.46 | 8.10 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -58.59 | -104.45 | -52.83 | -16.94 | -47.22 |
| Price-to-Operating Cash Flow Ratio | -61.15 | -104.45 | -53.59 | -19.68 | -49.39 |
| Price-to-Earnings Growth (PEG) Ratio | -6.09 | 2.79 | 1.72 | -0.24 | -2.97 |
| Enterprise Value Multiple | -42.34 | -67.65 | -65.92 | -11.45 | -43.18 |
| Enterprise Value | 1.33B | 1.96B | 2.63B | 623.97M | 879.67M |
| EV to EBITDA | -42.34 | -67.65 | -65.92 | -11.45 | -43.18 |
| EV to Sales | 22.21 | 39.07 | 95.72 | 47.78 | 91.38 |
| EV to Free Cash Flow | -51.84 | -94.66 | -48.75 | -11.73 | -44.69 |
| EV to Operating Cash Flow | -54.11 | -94.66 | -49.45 | -13.63 | -46.75 |
| Tangible Book Value Per Share | 10.62 | 12.53 | 14.28 | 20.73 | 14.76 |
| Shareholders’ Equity Per Share | 10.83 | 12.78 | 14.58 | 21.09 | 14.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 3.94 | 3.29 | 1.80 | 1.06 | 1.24 |
| Net Income Per Share | -1.95 | -1.80 | -2.51 | -4.43 | -2.64 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.91 | 0.91 | 0.93 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.50 | 0.54 | 0.75 | 2.01 | 1.42 |
| SG&A to Revenue | 0.67 | 0.70 | 1.22 | 2.68 | 1.39 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.83 | 0.76 | 1.39 | 0.84 | 0.92 |
Currency in TWD
